74 related articles for article (PubMed ID: 18572192)
1. Glucose regulates the expression of the apolipoprotein A5 gene.
Nowak M; Helleboid-Chapman A; Jakel H; Moitrot E; Rommens C; Pennacchio LA; Fruchart-Najib J; Fruchart JC
J Mol Biol; 2008 Jul; 380(5):789-98. PubMed ID: 18572192
[TBL] [Abstract][Full Text] [Related]
2. Insulin-mediated down-regulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: role of upstream stimulatory factor.
Nowak M; Helleboid-Chapman A; Jakel H; Martin G; Duran-Sandoval D; Staels B; Rubin EM; Pennacchio LA; Taskinen MR; Fruchart-Najib J; Fruchart JC
Mol Cell Biol; 2005 Feb; 25(4):1537-48. PubMed ID: 15684402
[TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone regulates the hypotriglyceridemic gene APOA5.
Prieur X; Huby T; Coste H; Schaap FG; Chapman MJ; Rodríguez JC
J Biol Chem; 2005 Jul; 280(30):27533-43. PubMed ID: 15941710
[TBL] [Abstract][Full Text] [Related]
4. Orphan nuclear receptor Nur77 participates in human apolipoprotein A5 gene expression.
Song KH
Biochem Biophys Res Commun; 2010 Jan; 392(1):63-6. PubMed ID: 20059973
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of apolipoprotein A5 gene expression by the nuclear receptor RORalpha.
Genoux A; Dehondt H; Helleboid-Chapman A; Duhem C; Hum DW; Martin G; Pennacchio LA; Staels B; Fruchart-Najib J; Fruchart JC
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1186-92. PubMed ID: 15790933
[TBL] [Abstract][Full Text] [Related]
6. Roles of USF, Ikaros and Sp proteins in the transcriptional regulation of the human reduced folate carrier B promoter.
Liu M; Whetstine JR; Payton SG; Ge Y; Flatley RM; Matherly LH
Biochem J; 2004 Oct; 383(Pt 2):249-57. PubMed ID: 15214842
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of cyclic AMP response element-binding protein H response element in the human apolipoprotein A5 gene promoter.
Song KH; Park AY; Kim JE; Ma JY
Biomed Res Int; 2013; 2013():892491. PubMed ID: 23957007
[TBL] [Abstract][Full Text] [Related]
8. Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?
Jakel H; Nowak M; Helleboid-Chapman A; Fruchart-Najib J; Fruchart JC
Ann Med; 2006; 38(1):2-10. PubMed ID: 16448983
[TBL] [Abstract][Full Text] [Related]
9. Upstream stimulatory factors, USF1 and USF2, bind to the human haem oxygenase-1 proximal promoter in vivo and regulate its transcription.
Hock TD; Nick HS; Agarwal A
Biochem J; 2004 Oct; 383(Pt 2):209-18. PubMed ID: 15242350
[TBL] [Abstract][Full Text] [Related]
10. Glucose increases hepatic lipase expression in HepG2 liver cells through upregulation of upstream stimulatory factors 1 and 2.
van Deursen D; Jansen H; Verhoeven AJ
Diabetologia; 2008 Nov; 51(11):2078-87. PubMed ID: 18758746
[TBL] [Abstract][Full Text] [Related]
11. Xuezhikang contributes to greater triglyceride reduction than simvastatin in hypertriglyceridemia rats by up-regulating apolipoprotein A5 via the PPARα signaling pathway.
Zhao SP; Li R; Dai W; Yu BL; Chen LZ; Huang XS
PLoS One; 2017; 12(9):e0184949. PubMed ID: 28934253
[TBL] [Abstract][Full Text] [Related]
12. Cooperative activation of lipocalin-type prostaglandin D synthase gene expression by activator protein-2beta in proximal promoter and upstream stimulatory factor 1 within intron 4 in human brain-derived TE671 cells.
Fujimori K; Urade Y
Gene; 2007 Aug; 397(1-2):143-52. PubMed ID: 17574780
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of the distal promoter of the rat pyruvate carboxylase gene by hepatocyte nuclear factor 3beta/Foxa2 and upstream stimulatory factors in insulinoma cells.
Boonsaen T; Rojvirat P; Surinya KH; Wallace JC; Jitrapakdee S
Biochem J; 2007 Jul; 405(2):359-67. PubMed ID: 17408383
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activators.
Vu-Dac N; Gervois P; Jakel H; Nowak M; Bauge E; Dehondt H; Staels B; Pennacchio LA; Rubin EM; Fruchart-Najib J; Fruchart JC
J Biol Chem; 2003 May; 278(20):17982-5. PubMed ID: 12637506
[TBL] [Abstract][Full Text] [Related]
15. The role of apolipoprotein A5 in obesity and the metabolic syndrome.
Zheng XY; Zhao SP; Yan H
Biol Rev Camb Philos Soc; 2013 May; 88(2):490-8. PubMed ID: 23279260
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus inhibits apolipoprotein A5 expression through its core gene.
Zhu C; Gao G; Song H; Xu F; Wu K; Liu X
Lipids Health Dis; 2016 Oct; 15(1):178. PubMed ID: 27724895
[TBL] [Abstract][Full Text] [Related]
17. Opposite expression of the antioxidant heme oxygenase-1 in primary cells and tumor cells: regulation by interaction of USF-2 and Fra-1.
Samoylenko A; Dimova EY; Horbach T; Teplyuk N; Immenschuh S; Kietzmann T
Antioxid Redox Signal; 2008 Jul; 10(7):1163-74. PubMed ID: 18331200
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice.
Pennacchio LA; Rubin EM
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):529-34. PubMed ID: 12615678
[TBL] [Abstract][Full Text] [Related]
19. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells.
Chang JT; Yang HT; Wang TC; Cheng AJ
Mol Carcinog; 2005 Nov; 44(3):183-92. PubMed ID: 16010690
[TBL] [Abstract][Full Text] [Related]
20. Aryl hydrocarbon receptor nuclear translocator and upstream stimulatory factor regulate Cytochrome P450 2a5 transcription through a common E-box site.
Arpiainen S; Lämsä V; Pelkonen O; Yim SH; Gonzalez FJ; Hakkola J
J Mol Biol; 2007 Jun; 369(3):640-52. PubMed ID: 17466327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
